ES2000437A4 - Procedimiento para potenciar el crecimiento del parenquima mamario. - Google Patents

Procedimiento para potenciar el crecimiento del parenquima mamario.

Info

Publication number
ES2000437A4
ES2000437A4 ES87870029T ES87870029T ES2000437A4 ES 2000437 A4 ES2000437 A4 ES 2000437A4 ES 87870029 T ES87870029 T ES 87870029T ES 87870029 T ES87870029 T ES 87870029T ES 2000437 A4 ES2000437 A4 ES 2000437A4
Authority
ES
Spain
Prior art keywords
growth
enhance
procedure
breast parenchyma
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES87870029T
Other languages
English (en)
Other versions
ES2000437T3 (es
Inventor
Robert Joseph Collier
Michael Francis Mcgrath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of ES2000437A4 publication Critical patent/ES2000437A4/es
Application granted granted Critical
Publication of ES2000437T3 publication Critical patent/ES2000437T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Dairy Products (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seasonings (AREA)
  • Catching Or Destruction (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Mushroom Cultivation (AREA)
  • Liquid Deposition Of Substances Of Which Semiconductor Devices Are Composed (AREA)

Abstract

EL CRECIMIENTO DEL PARENQUIMA MAMARIO PRODUCTOR DE LA LECHE EN UN MAMIFERO FISIOLOGICAMENTE NORMAL, PUEDE SER SIGNIFICATIVAMENTE MEJORADO POR ADMINISTRACION AL MAMIFERO A TRAVES DE INFUSION INTRAMAMARIA DE UNA SUSTANCIA QUE POSEE EFECTO MITOGENICO SOBRE LAS CELULAS EPITELIALES MAMARIAS DE DICHO MAMIFERO. UN BUEN CRECIMIENTO MEJORADO SE PUEDE LLEVAR A CABO UTILIZANDO CANTIDADES MUY PEQUEÑAS DE TALES SUSTANCIAS, Y EN PERIODOS RELATIVAMENTE CORTOS DE TIEMPO.
ES87870029T 1986-03-07 1987-03-04 Procedimiento para potenciar el crecimiento del parenquima mamario. Expired - Lifetime ES2000437T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83747786A 1986-03-07 1986-03-07

Publications (2)

Publication Number Publication Date
ES2000437A4 true ES2000437A4 (es) 1988-03-01
ES2000437T3 ES2000437T3 (es) 1994-01-16

Family

ID=25274560

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87870029T Expired - Lifetime ES2000437T3 (es) 1986-03-07 1987-03-04 Procedimiento para potenciar el crecimiento del parenquima mamario.

Country Status (22)

Country Link
US (1) US5059586A (es)
EP (1) EP0237514B1 (es)
JP (1) JPS62221635A (es)
KR (1) KR900000545B1 (es)
CN (1) CN87102601A (es)
AT (1) ATE93730T1 (es)
AU (1) AU595295B2 (es)
BG (1) BG50926A3 (es)
CA (1) CA1299103C (es)
CS (1) CS272772B2 (es)
DD (1) DD258943A5 (es)
DE (1) DE3787185T2 (es)
DK (1) DK116287A (es)
ES (1) ES2000437T3 (es)
HU (1) HU205007B (es)
IL (1) IL81809A (es)
MX (1) MX170911B (es)
NO (1) NO870946L (es)
NZ (1) NZ219530A (es)
PL (1) PL154182B1 (es)
RU (1) RU2033178C1 (es)
ZA (1) ZA871654B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130300A (en) * 1986-03-07 1992-07-14 Monsanto Company Method for enhancing growth of mammary parenchyma
US5182302A (en) * 1986-03-07 1993-01-26 Monsanto Company Method for enhancing growth of mammary parenchyma using a prostaglandin
US5130299A (en) * 1986-03-07 1992-07-14 Monsanto Company Method for enhancing growth of mammary parenchyma
IE912345A1 (en) * 1990-08-03 1992-02-12 Pharmacia Ab Treatment of human lactation failure
US5336488A (en) * 1991-08-07 1994-08-09 American Cyanamid Company Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines
US6828111B2 (en) 2000-01-13 2004-12-07 Wayne State University Three-dimensional in vitro model of human preneoplastic breast disease
RU2185198C2 (ru) * 2000-05-15 2002-07-20 Российский Университет Дружбы Народов Способ лечения кисты молочной железы
US6967090B2 (en) * 2001-05-18 2005-11-22 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food Nucleic acid and protein sequences of bovine epidermal growth factor
JP2017046688A (ja) * 2015-08-31 2017-03-09 株式会社みやぎヘルスイノベーション 体重増加抑制用飲料組成物
CN105194642B (zh) * 2015-10-09 2018-04-17 深圳市容大生物技术有限公司 一种疏通乳房微循环养护自体腺胞的组合物及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011312A (en) * 1975-06-25 1977-03-08 American Home Products Corporation Prolonged release drug form for the treatment of bovine mastitis
EP0085036A1 (en) * 1982-01-18 1983-08-03 Monsanto Company Method for improved bovine milk production
US4521409A (en) * 1983-10-03 1985-06-04 Cornell Research Foundation, Inc. Use of growth hormone to enhance ruminant mammary development

Also Published As

Publication number Publication date
AU6978887A (en) 1987-09-10
MX170911B (es) 1993-09-22
NZ219530A (en) 1992-12-23
IL81809A (en) 1993-01-31
CN87102601A (zh) 1987-12-16
IL81809A0 (en) 1987-10-20
DK116287D0 (da) 1987-03-06
DE3787185D1 (de) 1993-10-07
BG50926A3 (bg) 1992-12-15
EP0237514B1 (en) 1993-09-01
DE3787185T2 (de) 1994-02-03
PL264490A1 (en) 1988-02-18
DD258943A5 (de) 1988-08-10
HU205007B (en) 1992-03-30
NO870946L (no) 1987-09-08
KR880010773A (ko) 1988-10-24
EP0237514A1 (en) 1987-09-16
CS151887A2 (en) 1990-06-13
NO870946D0 (no) 1987-03-06
RU2033178C1 (ru) 1995-04-20
ATE93730T1 (de) 1993-09-15
CS272772B2 (en) 1991-02-12
KR900000545B1 (ko) 1990-01-31
JPS62221635A (ja) 1987-09-29
ES2000437T3 (es) 1994-01-16
CA1299103C (en) 1992-04-21
DK116287A (da) 1987-09-08
HUT47031A (en) 1989-01-30
AU595295B2 (en) 1990-03-29
PL154182B1 (en) 1991-07-31
ZA871654B (en) 1987-08-28
US5059586A (en) 1991-10-22

Similar Documents

Publication Publication Date Title
ES2000437A4 (es) Procedimiento para potenciar el crecimiento del parenquima mamario.
ES2194275T3 (es) Alimento para el cuidado dental de animales domesticos.
ES2021164T5 (es) Aparato para realizar micro-abrasiones en tejido humano.
NO821832L (no) Fremgangsmaate for fremstilling av allergenholdige kapsler
ES461761A1 (es) Un procedimiento para la preparacion de una composicion tin-torea para fibras queratinicas.
ES380632A1 (es) Un procedimiento para la preparacion de colorantes de tipo indo como las indoanilinas.
ES2140392T3 (es) Metodo y composicion para mejorar los efectos adversos del envejecimiento.
FR2203618A1 (en) Dentifrice compsn contg indicating dye - consisting of chlorophyl, tartrazine patent blue, to show up the dental plaque
ES2039460T3 (es) Un procedimiento para producir una solucion inyectable de glicosido de antraciclina.
Van Vleck The anatomy of the nasal rays of Condylura cristata
Hussey The miracidium of Proterometra macrostoma (Faust) Horsfall 1933
FR2424701A1 (fr) Composition fongicide a base de triazole et procede de traitement fongicide de plantes cultivees
USD222847S (en) Miniature air compressor or the like
USD227896S (en) Inter-dental flossing device
USD222137S (en) Fisherman s tool
USD234162S (en) Sanitary napkin
Park et al. Immature stages of Paracycnotrachelus longiceps (Motschulsky)(Coleoptera: Attelabidae: Apoderinae) from Korea
USD203062S (en) Combined wrist support and flashlight therefor
CO4480034A1 (es) Formulaciones farmaceuticas a partir de rhizophora mangle l
DE3865642D1 (de) Pharmazeutische zubereitung zur cholelitholyse.
USD215761S (en) Spectacle front
Curran ON THE GENUS ARCTOPHYTO TOWNSEND IN NORTH AMERICA (TACHINIDAE, DIPTERA)
FR2421609A1 (fr) Creme dermique de jour a la gelee naturelle d'orange
Aird MY MOTHER'S GRAVE.
ES2088744B1 (es) Jarabe medicinal artesano.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 237514

Country of ref document: ES